Examkin

Question

Difficulty: MediumInfectious Diseases

During morning rounds on the general medical ward, a physician evaluates a 6868-year-old man undergoing treatment for severe community-acquired pneumonia. The patient was admitted 33 days ago with acute respiratory distress, fever, and a dense right lower lobe consolidation on chest radiography. Due to a history of a recent hospitalization 66 weeks prior, he was started on empiric intravenous vancomycin and piperacillin-tazobactam.

The patient's condition has markedly improved over the past 4848 hours. He is now breathing comfortably on room air, and his cough is producing only minimal clear sputum. His temperature is 37.2∘37.2^\circ C (99.0∘99.0^\circ F), blood pressure is 130/82130/82 mmHg, pulse is 7878/min, and respirations are 1616/min. Blood cultures drawn at the time of admission are now positive for *Streptococcus pneumoniae* in two out of two bottles. Antimicrobial susceptibility testing demonstrates that the isolate is sensitive to penicillin, amoxicillin, ceftriaxone, and linezolid, but resistant to azithromycin.

Which of the following is the most appropriate next step in this patient's pharmacotherapy?

  1. Discontinue the current regimen and initiate oral amoxicillinAnswer
  2. B
    Maintain intravenous vancomycin and piperacillin-tazobactam for a total of 77 days
  3. C
    Discontinue vancomycin but continue intravenous piperacillin-tazobactam
  4. D
    Transition the patient to oral linezolid
  5. E
    Transition the patient to oral amoxicillin-clavulanate

Answer

Discontinue the current regimen and initiate oral amoxicillin.
The correct course of action is to discontinue the broad-spectrum intravenous antibiotics and initiate a narrow-spectrum oral agent (amoxicillin). This patient initially required broad-spectrum coverage (vancomycin and piperacillin-tazobactam) due to his severe presentation and healthcare exposure risk. However, he is now clinically stable, afebrile, and tolerating oral intake. Blood cultures have isolated *Streptococcus pneumoniae* susceptible to penicillin. According to strict antibiotic stewardship guidelines, therapy should be de-escalated to the narrowest effective agent as soon as culture and sensitivity data are available. High-dose oral amoxicillin is the preferred agent for penicillin-susceptible *S. pneumoniae*.

Step-by-Step Solution

1
Evaluate the patient's clinical trajectory and readiness for step-down therapy.
The patient's vital signs have normalized, his respiratory distress has resolved, and he is breathing comfortably on room air.
Demonstrating clinical stability is the first prerequisite before converting from intravenous to oral antimicrobial therapy.
2
Interpret the blood culture and susceptibility data.
Cultures isolate Streptococcus pneumoniae that is susceptible to narrow-spectrum beta-lactams including penicillin and amoxicillin.
Targeted culture data must be used to adjust the initial empiric broad-spectrum therapy.
3
Select the most appropriate definitive targeted therapy.
Oral amoxicillin is selected as the optimal definitive regimen.
Amoxicillin provides highly effective, narrow-spectrum coverage for penicillin-susceptible S. pneumoniae, adhering to core antibiotic stewardship principles by minimizing collateral damage to the microbiome.

Key Concept

Antibiotic stewardship requires the de-escalation of empiric broad-spectrum antimicrobial therapy to targeted, narrow-spectrum oral agents once a patient demonstrates clinical improvement and culture susceptibilities are available.
Estimated Time:1m 30s
Rate this question

Topics

Infectious Diseases

More questions from this topic